Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/10/22
End: 09/10/23
Due: 09/10/24
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 09/01/24
Due: 09/01/25
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 12/20/22
End: 10/01/24
Due: 10/01/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Fospropofol Disodium Versus Propofol for Sedation in Mechanically Ventilated ICU Patients | NCT05491278 | Xiaobo Yang, MD | user2@example.com | None | 2022-08-10 | 2023-09-10 | 2024-09-10 | - | - | 2025-07-14 |
| The Effects of ECMO on the Pharmacokinetics of Hydromorphone | NCT05565495 | Xiaobo Yang, MD | user2@example.com | None | 2022-01-01 | 2024-09-01 | 2025-09-01 | - | - | 2025-07-14 |
| Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients | NCT05870514 | Xiaobo Yang, MD | user2@example.com | None | 2023-06-01 | 2024-06-01 | 2025-06-01 | - | - | 2025-07-14 |
| Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulation | NCT05555641 | Xiaobo Yang, MD | user2@example.com | None | 2022-12-20 | 2024-10-01 | 2025-10-01 | - | - | 2025-07-14 |